Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Cytori Therapeutics Company Profile (NASDAQ:CYTX)

Consensus Ratings for Cytori Therapeutics (NASDAQ:CYTX) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $3.40 (37.10% upside)

Analysts' Ratings History for Cytori Therapeutics (NASDAQ:CYTX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
1/22/2014ZacksDowngradeOutperform -> Neutral$3.40ViewTweet This Rating  Share This Rating on StockTwits
12/24/2013ZacksUpgradeNeutral -> Outperform$2.80ViewTweet This Rating  Share This Rating on StockTwits
9/10/2013Roth CapitalInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
7/16/2013ZacksDowngradeOutperform -> Neutral$2.90ViewTweet This Rating  Share This Rating on StockTwits
3/6/2013Roth CapitalInitiated CoverageBuy$8.00ViewTweet This Rating  Share This Rating on StockTwits
2/20/2013Ascendiant Capital MarketsInitiated CoverageBuy$3.25ViewTweet This Rating  Share This Rating on StockTwits
9/28/2012Maxim GroupReiterated RatingBuy$10.00ViewTweet This Rating  Share This Rating on StockTwits
9/7/2012Maxim GroupInitiated CoverageBuy$10.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/25/2012 forward)